Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer.
Matsumura Y, Gotoh M, Muro K, Yamada Y, Shirao K, Shimada Y, Okuwa M, Matsumoto S, Miyata Y, Ohkura H, Chin K, Baba S, Yamao T, Kannami A, Takamatsu Y, Ito K, Takahashi K.
Matsumura Y, et al. Among authors: miyata y.
Ann Oncol. 2004 Mar;15(3):517-25. doi: 10.1093/annonc/mdh092.
Ann Oncol. 2004.
PMID: 14998859
Free article.
Clinical Trial.